Showing 101-105 of 169 news & articles:
Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry

Springer Link Publish Date: November 4, 2022 Read the Full Article >>   Abstract Background There is limited evidence on the clinical and economic benefit of achieving disease control in psoriatic arthritis (PsA) and ankylosing spondylitis (AS), thus we aimed to assess the impact of disease control on healthcare resource use (HCRU) and direct medical[…]

Many Female Arthritis Drug Users Face Restrictions After Dobbs

Bloomberg Law Publish Date: November 14, 2022 Read the Full Article >> More than half of women ages 15 to 49 who use a common arthritis drug risk losing access under restrictive state abortion laws, according to a new study based on nationwide health-care data. The analysis, published Saturday in the Arthritis & Rheumatology Journal, found[…]

Personalizing Medicine: AI and RWE in the Medtech Context

AdvaMed Publish Date: November 3, 2022 Read the Full Article>> Challenges of AI in MedTech In the medical device space, powerful insights from real-world data can seem ‘just out of reach’. Capturing patient characteristics and outcomes, at scale and with consistency over time, is challenging outside of clinical trials. Personalization – bridging the gap between[…]

Using Real-World Data to Understand Treatment Resistant Depression

Listen to OM1’s podcast episode on the Medical Affairs Professional Society (MAPS) “Elevate” podcast series. Dr. Carl Marci is discussing the use of Real-World Data and Real-World Evidence to understand and possibly intercede in treatment-resistant depression and why it is especially difficult to develop treatments against resistant depression using the traditional structure of R&D-led clinical[…]

How’d They Do It? Tech Leaders Reflect on How They Innovated To Solve Health Problems

Built In Publish Date: September 9, 2022 Read the Full Article >> About the company: Founded in 2015, OM1 developed its data cloud to provide advanced technological tools for researchers and support their quest to find new ways of understanding and treating chronic conditions. Yaning Zhang, Sr. Software Engineer, shared how OM1 turns data into insight:[…]